T-Cypher Bio Presents Promising Data on Two T Cell Engager Development Candidates for High Copy Number Cancer Targets at the 2026 Society for Immunotherapy of Cancer (SITC) Annual Meeting
The issuer is solely responsible for the content of this announcement.